Bayer spies an end to a long legal battle
The Economist
March 5, 2026
Bill Anderson, Bayer's chief executive, updates investors on his turnaround plan for the German drugs and chemicals firm following its disastrous Monsanto acquisition.
Verticals
businesseconomics
Originally published on The Economist on 3/5/2026